CSBR:NASDAQ
Champions Oncology Inc
$4.61
arrow_downward
-0.83%(-0.039) 1D
Nov 13, 1:36:47 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.57
High
$4.67
Low
$4.52
Mkt. cap
64.18M
Avg. vol.
8.16K
Volume
2.15K
52-wk high
$8.31
52-wk low
$4.52
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.57
High
$4.67
Low
$4.52
Mkt. cap
64.18M
Avg. vol.
8.16K
Volume
2.15K
52-wk high
$8.31
52-wk low
$4.52
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
37 minutes ago
S&P 500 Most Active Stocks: Nov. 13, 2026 Session
Yahoo Finance
·
47 minutes ago
Goldman Sachs sees upside for S&P 500 in 2027 — even as earnings growth slows
FOREX.com
·
1 hour ago
S&P 500 forecast: SPX struggles for direction ahead of PPI data
www.tokenpost.com
·
1 hour ago
Bitcoin Fell in 92% of S&P 500’s Worst 5% Return Periods Since 2022
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com